Abstract highlights Delcath's CHEMOSAT
May 29, 2015 at 18:59 PM EDT
An
online abstract at the American Society of Clinical Oncology Annual
Meeting 2015 highlighted Delcath Systems Inc.'s (Nasdaq: DCTH) Hepatic
CHEMOSAT Delivery System sending the stock price up 25 cents to close at $1.44.
